Larimar Therapeutics, Inc. (LRMR) News Headlines

▮ More

Date

Headline

3/14/2023 7:03:55 AM Larimar Therapeutics Q4 Net Loss $9.4 Mln Or $0.21/Shr Vs Loss Of $9.1 Mln Or $0.50/Shr Last Year

8/12/2022 7:26:19 AM Pre-market Movers: NEPT, OLO, LAW, CODX, LRMR…

3/25/2022 7:28:51 AM Larimar Therapeutics Q4 Net Loss $9.1 Mln Or $0.50/Shr Vs Loss Of $14.2 Mln Or $0.89/Shr Last Year

2/15/2022 4:56:32 PM William Blair Lowers Larimar Therapeutics, Inc. (LRMR) To Market Perform From Outperform

2/15/2022 7:59:14 AM Pre-market Movers: RESN, LRMR, TSEM, IPW, SBEV…

5/26/2021 10:37:11 AM Stock Alert: Larimar Therapeutics Tanks 40%

5/26/2021 12:49:52 AM LRMR Hit By 'double Whammy', PRVB On Watch, TLC Comes To India's Rescue To Fight Black Fungus

5/25/2021 11:39:34 PM FDA Places Clinical Hold On Larimar's CTI-1601 Clinical Program; Stock Plunges

5/11/2021 10:22:29 AM Stock Alert: Larimar Therapeutics Down 14%

8/12/2019 7:52:50 AM Wedbush Is Cutting Zafgen, Inc (ZFGN) FY20 Estimate To -0.96 From -0.88

8/12/2019 7:52:36 AM Wedbush Is Cutting Zafgen, Inc (ZFGN) Q4 20 Estimate To -0.24 From -0.22

8/12/2019 7:51:54 AM Wedbush Is Lowering Zafgen, Inc (ZFGN) Q3 20 Estimate To -0.25 From -0.23

8/12/2019 7:51:34 AM Wedbush Is Lowering Zafgen, Inc (ZFGN) Q2 20 Estimate To -0.24 From -0.22

8/12/2019 7:51:23 AM Wedbush Is Lowering Zafgen, Inc (ZFGN) Q1 20 Estimate To -0.24 From -0.22

8/12/2019 7:51:00 AM Wedbush Is Lowering Zafgen, Inc (ZFGN) FY19 Estimate To -1.22 From -1.12

8/12/2019 7:50:46 AM Wedbush Is Cutting Zafgen, Inc (ZFGN) Q4 19 Estimate To -0.26 From -0.23

8/12/2019 7:50:27 AM Wedbush Is Lowering Zafgen, Inc (ZFGN) Q3 19 Estimate To -0.29 From -0.25

8/12/2019 7:49:35 AM Wedbush Reiterates Zafgen, Inc (ZFGN) At Outperform With $6 Price Target

8/8/2018 8:54:47 AM Wedbush Is Increasing Zafgen, Inc (ZFGN) FY19 Estimate To -1.82 From -1.97

8/8/2018 8:54:30 AM Wedbush Is Increasing Zafgen, Inc (ZFGN) FY18 Estimate To -1.99 From -2.09